Form 8-K - Current report:
SEC Accession No. 0001641172-25-010541
Filing Date
2025-05-15
Accepted
2025-05-15 08:30:32
Documents
28
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42421
2 EX-99.1 ex99-1.htm EX-99.1 49377
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3551
4 EX-99.2 ex99-2.htm EX-99.2 12190
5 GRAPHIC ex99-2_001.jpg GRAPHIC 424032
6 GRAPHIC ex99-2_002.jpg GRAPHIC 1498808
7 GRAPHIC ex99-2_003.jpg GRAPHIC 479645
8 GRAPHIC ex99-2_004.jpg GRAPHIC 829185
9 GRAPHIC ex99-2_005.jpg GRAPHIC 714914
10 GRAPHIC ex99-2_006.jpg GRAPHIC 1310203
11 GRAPHIC ex99-2_007.jpg GRAPHIC 720645
12 GRAPHIC ex99-2_008.jpg GRAPHIC 762313
13 GRAPHIC ex99-2_009.jpg GRAPHIC 635129
14 GRAPHIC ex99-2_010.jpg GRAPHIC 931178
15 GRAPHIC ex99-2_011.jpg GRAPHIC 800819
16 GRAPHIC ex99-2_012.jpg GRAPHIC 571092
  Complete submission text file 0001641172-25-010541.txt   13603760

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE ltrn-20250515.xsd EX-101.SCH 3029
18 XBRL LABEL FILE ltrn-20250515_lab.xml EX-101.LAB 34239
19 XBRL PRESENTATION FILE ltrn-20250515_pre.xml EX-101.PRE 22368
30 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3833
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 25948924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)